He experiences partial relief from pain with home oxycodone q6h.
Status post platinum-based chemotherapy (agents and doses unknown but we suspect cisplatin/etoposide) and thoracic radiation (fields and does unknown) in [**2168-9-30**] attaining a partial response (treatment performed in [**Country 651**]).
Status post erlotinib monotherapy started on [**2171-3-1**] (at [**Hospital1 79384**] [[**Hospital1 18**]]).
Initial partial response  prior to radiographic progression at the 6-month plus mark of erlotinib therapy.
Status post erlotinib 150 mg/day + R1507 (IGF-1R antibody) on  [**2171-12-31**].
Status post 26 cycles of carboplatin and pemetrexed.
Status post 6 cycles of carboplatin 5 AUC and pemetrexed 500 mg/m2 from  [**2172-2-3**] to [**2172-5-19**].
Status post 4 cycles (cycle 7, 8, 9, 10) of single [**Doctor Last Name 360**] maintenance pemetrexed 500 mg/m2 from [**2172-6-9**] to [**2172-8-25**].
Status post 16 cycles (cycle 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26) of carboplatin 2.5->4 AUC and pemetrexed 500 mg/m2 on [**2172-9-15**], [**2172-10-6**], [**2172-10-27**], [**2172-11-17**], [**2172-12-8**], [**2172-12-29**], [**2173-1-19**], [**2173-2-16**], [**2173-3-9**], [**2173-3-30**], [**2173-4-20**], [**2173-5-11**], [**2173-6-1**], [**2173-6-22**], [**2173-7-13**], [**2173-8-10**], [**2173-10-5**].
Continued on erlotinib at 25 mg/day.
Status post 3000 cGy of whole brain radiotherapy completed on  [**2174-3-15**].
Started erlotinib 100 mg/day and MM-121 20 mg/kg D1, D15 of a  28-day cycle on [**2174-4-26**].
Status post 2 cycles (last infusion of  MM-121 20 mg/kg on [**2174-6-7**] and last dose of erlotinib 100 mg/day on [**2174-6-20**]).
Social History: The patient started smoking cigarettes at age 16 and quit at age 50.
ACTIVE ISSUES:  # Metastatic lung cancer: Patient referred by PCP for evaluation by Radiation Oncology and Ortho Spine Surgery to determine the role of radiation therapy and/or spinal fusion to prevent cord compression.
Patient continued erlotinib therapy in the hospital.
Due to extensive disease, Radiation Oncology team decided that surgical treatment would be the initial best approach.
Patient underwent spine surgery on [**10-1**] and [**10-2**].
Pain was well controlled with oxycontin 20 mg [**Hospital1 **], acetaminophen 650 mg q6h, and ibuprofen 600 mg tid, with oxycodone for breakthrough.
Ibuprofen was discontinued in preparation for surgery.
Nausea was controlled with zofran 8mg PRN.
Mr. [**Known lastname **] was transferred to the [**Hospital1 18**] Spine Surgery Service on [**2173-9-29**] and taken to the Operating Room for a T12 vertebrectomy through an anterior approach.
The surgery was without complication and the patient was transferred to the PACU in a stable condition.
Intravenous antibiotics were given per standard protocol.
He returned to the operating room for a scheduled T10-L2 decompression with PSIF as part of a staged 2-part procedure.
A bupivicaine epidural pain catheter placed at the time of the posterior surgery remained in place until postop day one.
He was kept NPO until bowel function returned then diet was advanced as tolerated.
The patient was transitioned to oral pain medication when tolerating PO diet.
Foley was removed on POD#2 from the second procedure.
On the day of discharge the patient was afebrile with stable vital signs, comfortable on oral pain control and tolerating a regular diet.
Medications on Admission: Preadmission medications listed are correct and complete.
OxycoDONE (Immediate Release)  5-10 mg PO Q6H:PRN pain 2.
Erlotinib 25 mg PO DAILY Start: In am 3.
Senna 1 TAB PO BID:PRN constipation Start: In am   Discharge Medications: 1.
OxycoDONE (Immediate Release)  5-10 mg PO Q6H:PRN pain RX *oxycodone 5 mg [**1-31**] tablet(s) by mouth every four (4) hours Disp #*100 Tablet Refills:*0 2.
Senna 1 TAB PO BID:PRN constipation RX *sennosides [senna] 8.6 mg 1 tab by mouth twice a day Disp #*60 Tablet Refills:*0 3.
Midodrine 5 mg PO TID RX *midodrine 5 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills:*0 4.
Neutra-Phos 1 PKT PO TID RX *potassium & sodium phosphates [Phos-NaK] 280 mg-160 mg-250 mg 1 Powder(s) by mouth once a day Disp #*30 Tablet Refills:*0 5.
Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 6.
Polyethylene Glycol 17 g PO DAILY:PRN Constipation RX *polyethylene glycol 3350 17 gram 1 packet by mouth once a day Disp #*30 Tablet Refills:*0 7. traZODONE 25 mg PO HS:PRN insomnia RX *trazodone 50 mg 0.5 (One half) tablet(s) by mouth at bedtime Disp #*60 Tablet Refills:*0 8.
Erlotinib 25 mg PO DAILY   Discharge Disposition: Home With Service  Facility: Multicultural VNA  Discharge Diagnosis: T12 metastatic leision   Discharge Condition: Good   Discharge Instructions: You have undergone the following operation: ANTERIOR corpectomy T12 with T10-L2 posterior fusion with instrumentation   Immediately after the operation:    -Activity: You should not lift anything greater than 10 lbs for 2 weeks.
-Rehabilitation/ Physical Therapy:  o2-3 times a day you should go for a walk for 15-30 minutes as part of your recovery.
You have been given medication to help with this issue.
-Wound Care: Remove the dressing in 2 days.
-You have also been given Additional Medications to control your pain.
In addition, we are only allowed to write for pain medications for 90 days from the date of surgery.
Please call the office if you have a fever>101.5 degrees Fahrenheit and/or drainage from your wound.
